the in vitro activity of ciprofloxacin and its human pharmacology suggest a twice daily 250 of 500 mg dosing for infections caused by multiple antibiotic-resistant bacteria , and a once a day dose in the treatment of urinary tract infections .
C0008809
ciprofloxacin
C0042029
of urinary tract infections